UAB Cardiothoracic Surgery Annual Report 2015-16 UAB Medicine Cardiothoracic Surgery 2015/16 Annual | Page 14

ADULT CARDIAC SURGERY

OUTCOMES
UAB’s TAVR Mortality, August 2012 – 2015
2012 – 2014

2015

TAVR Volumes

202

166

Mortality

6

2

Percent Mortality

3.0%

1.2%

STS/ACC TVT Benchmark

3.3%

UAB’s TAVR mortality for August 2012 through 2015 is lower than the STS/ACC TVT Registry Benchmark.
(Source: STS/ACC TVT Registry 2015 Q2 Outcomes Report – RQ4).

UAB’s valve team has utilized various techniques for implantation of the TAVR valve,
tailored to the needs of the patient.
TRANSFEMORAL
APPROACH

71%

OF CASES

TRANSAPICAL
APPROACH

TRANSAORTIC
APPROACH

12%
OF CASES

17%

OF CASES

92% of transcatheter aortic valve replacements
are implanted transfemorally utilizing the Edwards Sapien 3 transcatheter heart
(aortic) valve. (Image used with permission)

The Medtronic CoreValve Evolut R
is approved for TAVR procedures and for valve-in-valve procedures in the aortic
position. (Image used with permission)

12

Cardiothoracic Surgery Annual Report